Medpace Holdings CEO August J. Troendle Sells $403K in Stock
Medpace Holdings, Inc.
Subscribe to track MEDP
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Medpace Holdings, Inc. ($MEDP) š¤ Troendle August J. (President & CEO, Director, 10% Owner)
Transaction Details: ā¢ Type: Sale (Open Market) ā¢ Shares Sold: 650 ā¢ Price: $620.27 ā¢ Total Value: $403,175.50 ā¢ Date: August 27, 2026 ā¢ Direct Shares Remaining: 539,894 ā¢ Indirect Holdings: 4,733,019 shares via Medpace Investors, LLC
Significance: Low (represents a tiny fraction of total holdings)
Comprehensive Analysis
Insider Transaction Overview
On August 27, 2026, August J. Troendle, President, CEO, Director, and 10% Owner of Medpace Holdings, Inc. ($MEDP), executed an open-market sale of 650 shares of Common Stock at a weighted average price of $620.27 per share, totaling approximately $403,175.50.
Transaction Breakdown
- Date: August 27, 2026
- Transaction Type: Open Market Sale (
S) - Shares Sold: 650 shares
- Average Price: $620.27 (range: $620.00 ā $621.28)
- Total Consideration: $403,175.50
- Post-Transaction Direct Ownership: 539,894 shares
- Indirect Ownership: 4,733,019 shares held via Medpace Investors, LLC
Analysis & Significance
- Trading Significance: Low
- Context: The transaction was executed pursuant to a limit order placed during an open trading window. Given that Troendle continues to beneficially own more than 5.27 million shares across direct and indirect holdings, the sale of 650 shares represents less than 0.02% of his total equity interest in Medpace Holdings, Inc.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.